MENUNews Archive
Date: 10/24/2014
A new comprehensive analysis of thyroid cancer from The Cancer Genome Atlas Research Network has identified markers of aggressive tumors, which could allow for better targeting of appropriate treatments to individual patients.
Date: 10/23/2014
Nearly two-thirds of patients treated for colorectal cancer reported some measure of financial burden due to their treatment, according to a new study from researchers at the University of Michigan Rogel Cancer Center. The burden was greatest among patients who received chemotherapy.
Date: 10/20/2014
From the University of Michigan Rogel Cancer Center, head and neck surgeon Carol R. Bradford, M.D., chair of otolaryngology-head and neck surgery, was elected to the Institute of Medicine in recognition of her major contributions to the advancement of the medical sciences, health care and public health.
Date: 10/07/2014
Where patients live in the country may determine whether they receive minimally invasive colon cancer surgery, a new study from U-M Rogel Cancer Center researchers finds.
Date: 10/01/2014
The majority of patients diagnosed with sarcoma will be cured of their disease and live cancer-free. But as they age, these patients are at risk of developing another medical condition related to their sarcoma treatment.A new clinic opening this week at the University of Michigan aims to help adults who were treated for sarcoma, a cancer of the bone and connective tissue.
Date: 10/01/2014
Media contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer AnswerLine™, 800-865-1125
Date: 09/23/2014
Media contact: Nicole Fawcett, 734-764-2220 | Patients may contact Cancer AnswerLine™, 800-865-1125
Date: 09/04/2014
Gene therapy developed by Dr. Maria Castro and Dr. Pedro Lowenstein will now get the first test in human patients. The experimental approach, based on their research while at the University of Michigan, delivers two different genes directly into the brains of patients following the operation to remove the bulk of their tumors.
Date: 09/04/2014
Researchers at the University of Michigan School of Nursing and Rogel Cancer Center have received a $2.3 million grant to study oncology nurses’ exposure to hazardous drugs, including identifying ways to reduce exposure. According to Christopher Friese, Ph.D., R.N., AOCN, FAAN, University of Michigan School of Nursing assistant professor and member of U-M’s Rogel Cancer Center and Institute for Healthcare Policy and Innovation, there are significant acute and long-term side effects from hazardous drug exposures in oncology settings, but not enough evidence-based, risk-reduction efforts to protect health care workers.
Date: 08/12/2014
The content on this page is out of date. To learn about fundraising events, please visit the Community Events page.